Yamagata T - Search Results

1

AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.

Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, Yamagata T, Mitani K, Chiba S, Ogawa S, Kurokawa M, Hirai H. Ichikawa M, et al. Among authors: yamagata t. Nat Med. 2004 Mar;10(3):299-304. doi: 10.1038/nm997. Epub 2004 Feb 15. Nat Med. 2004. PMID: 14966519

2

AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.

Yamaguchi Y, Kurokawa M, Imai Y, Izutsu K, Asai T, Ichikawa M, Yamamoto G, Nitta E, Yamagata T, Sasaki K, Mitani K, Ogawa S, Chiba S, Hirai H. Yamaguchi Y, et al. Among authors: yamagata t. J Biol Chem. 2004 Apr 9;279(15):15630-8. doi: 10.1074/jbc.M400355200. Epub 2004 Jan 29. J Biol Chem. 2004. PMID: 14752096 Free article.

3

Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression.

Kumano K, Chiba S, Shimizu K, Yamagata T, Hosoya N, Saito T, Takahashi T, Hamada Y, Hirai H. Kumano K, et al. Among authors: yamagata t. Blood. 2001 Dec 1;98(12):3283-9. doi: 10.1182/blood.v98.12.3283. Blood. 2001. PMID: 11719365 Free article.

4

Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.

Waga K, Nakamura Y, Maki K, Arai H, Yamagata T, Sasaki K, Kurokawa M, Hirai H, Mitani K. Waga K, et al. Among authors: yamagata t. Oncogene. 2003 Jan 9;22(1):59-68. doi: 10.1038/sj.onc.1206072. Oncogene. 2003. PMID: 12527908

5

Impaired spermatogenesis and male fertility defects in CIZ/Nmp4-disrupted mice.

Nakamoto T, Shiratsuchi A, Oda H, Inoue K, Matsumura T, Ichikawa M, Saito T, Seo S, Maki K, Asai T, Suzuki T, Hangaishi A, Yamagata T, Aizawa S, Noda M, Nakanishi Y, Hirai H. Nakamoto T, et al. Among authors: yamagata t. Genes Cells. 2004 Jun;9(6):575-89. doi: 10.1111/j.1356-9597.2004.00746.x. Genes Cells. 2004. PMID: 15189450 Free article.

6

Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos.

Maki K, Yamagata T, Asai T, Yamazaki I, Oda H, Hirai H, Mitani K. Maki K, et al. Among authors: yamagata t. Blood. 2005 Sep 15;106(6):2147-55. doi: 10.1182/blood-2004-11-4330. Epub 2005 May 24. Blood. 2005. PMID: 15914564 Free article.

7

Runx1/AML1 in normal and abnormal hematopoiesis.

Yamagata T, Maki K, Mitani K. Yamagata T, et al. Int J Hematol. 2005 Jul;82(1):1-8. doi: 10.1532/IJH97.05075. Int J Hematol. 2005. PMID: 16105753 Review.

8

Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance.

Seo S, Asai T, Saito T, Suzuki T, Morishita Y, Nakamoto T, Ichikawa M, Yamamoto G, Kawazu M, Yamagata T, Sakai R, Mitani K, Ogawa S, Kurokawa M, Chiba S, Hirai H. Seo S, et al. Among authors: yamagata t. J Immunol. 2005 Sep 15;175(6):3492-501. doi: 10.4049/jimmunol.175.6.3492. J Immunol. 2005. PMID: 16148091

9

Role of the RUNX1-EVI1 fusion gene in leukemogenesis.

Maki K, Yamagata T, Mitani K. Maki K, et al. Among authors: yamagata t. Cancer Sci. 2008 Oct;99(10):1878-83. doi: 10.1111/j.1349-7006.2008.00956.x. Cancer Sci. 2008. PMID: 19016745 Free PMC article. Review.

10

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, Tamura A, Honda H, Sakata-Yanagimoto M, Kumano K, Oda H, Yamagata T, Takita J, Gotoh N, Nakazaki K, Kawamata N, Onodera M, Nobuyoshi M, Hayashi Y, Harada H, Kurokawa M, Chiba S, Mori H, Ozawa K, Omine M, Hirai H, Nakauchi H, Koeffler HP, Ogawa S. Sanada M, et al. Among authors: yamagata t. Nature. 2009 Aug 13;460(7257):904-8. doi: 10.1038/nature08240. Epub 2009 Jul 20. Nature. 2009. PMID: 19620960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

821 results

Search Page

Filters